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present in the donor (or contralateral) common femoral
artery. The bilateral groins and lower abdomen are sterilely
cleaned with Betadine solution. The superficial femoral
artery (SFA) in the ischemic limb is imaged with ultrasound
scanning guidance and punctured percutaneously by using
a Micropuncture Introducer Set (Cook, Bloomington,
Ind). After the insertion of the guidewire, a 7F Super Arrow
Flex introducer sheath (Arrow International, Reading, Pa)
is inserted in an antegrade fashion in the SFA just below the
IABP catheter site. The contralateral common femoral
artery is accessed percutaneously, and then a 9F Super
Since its introduction nearly four decades ago, the intra-
aortic balloon pump (IABP) has been embraced as a useful
device for providing temporary cardiac support in patients
with ischemic myocardium. The complication rate associ-
ated with IABP placement ranges from 8% to 18%, and
complications include limb ischemia, pseudoaneurysm, ile-
ofemoral artery dissection, thromboembolism, and local-
ized wound infection.1,2 Numerous reports have noted that
acute lower-limb ischemia is the most common complica-
tion caused by IABP insertion.3,4 When acute limb ischemia
occurs as a result of IABP placement, the IABP should be
weaned and removed as soon as clinically possible. In IABP-
dependent patients in whom acute limb ischemia develops,
an extra-anatomic bypass grafting procedure, such as a
femorofemoral bypass grafting procedure, may be required
to maintain the lower-extremity perfusion. In this report,
we describe a percutaneous endovascular technique for cre-
ating a temporary femorofemoral bypass graft to relieve
acute leg ischemia caused by IABP placement.
METHOD
Before placing the percutaneous femorofemoral bypass
graft, a thorough physical examination is critical as a means
of ensuring that the Doppler pedal signal is absent in the
IABP-inserted (or ipsilateral) leg, and a palpable pulse is
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TECHNICAL NOTE
Percutaneous bedside femorofemoral bypass
grafting for acute limb ischemia caused by 
intra-aortic balloon pump
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Acute limb ischemia is a common, recognized complication of intra-aortic balloon pump (IABP) placement in patients
with failing myocardium, and an operative femorofemoral bypass graft is often necessary in IABP-dependent patients
as a means of maintaining the lower-limb perfusion. In this report, we present a minimally invasive endovascular tech-
nique for creating a percutaneous temporary femorofemoral bypass graft at bedside in patients with IABP-induced limb
ischemia. This temporary bypass grafting technique may obviate a potential graft infection or wound complications
associated with a formal femorofemoral bypass graft. (J Vasc Surg 2002;35:592-4.)
Fig 1. With ultrasound scanning guidance, a 7F introducer
sheath was inserted in an antegrade fashion in the superficial
femoral artery just below the IABP catheter site. The contralateral
common femoral artery was accessed percutaneously, and then a
9F introducer sheath was inserted in a retrograde fashion.
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Arrow Flex introducer sheath is inserted in a retrograde
fashion (Fig 1). Next, the dilators of both introducer
sheaths are trimmed to a 2-cm segment. A 40-cm-long, 8-
mm polytet-rafluoroethylene (PTFE) graft (WL Gore,
Flagstaff, Ariz) is connected to the end of each dilator and
secured with 2-0 silk ligatures. The dilators are inserted to
their respective introducer sheaths (Fig 2). The insertion of
the shortened dilator into the introducer sheath keeps the
one-way valve open, which establishes a femorofemoral
bypass graft from the contralateral common femoral artery
to the ipsilateral ischemic SFA (Fig 3). It is important to
connect the donor femoral sheath first to allow the PTFE
graft to be filled with blood before connecting to the
ischemic SFA introducer sheath, which minimizes potential
distal air embolism. A heparinized saline solution is con-
nected and infused via the side port of the contralateral
introducer sheath to maintain a partial thromboplastin time
that is 1.5 times the baseline level. The introducer sheaths
are securely attached to the skin with 2-0 nylon sutures, and
60-cm by 45-cm Ioban sterile drapes (3M, St. Paul, Minn)
are used to tape the PTFE graft and the bilateral groin
introducer sheaths.
Once the patient has been successfully weaned off the
IABP, the IABP catheter is removed from the patient, and
the femoral artery is closed by using a 10F Prostar percu-
taneous closure device (Redwood City, Calif). Before the
femoral graft is disconnected and the groin sheaths are
removed, the PTFE graft is test-clamped to ensure that
the ipsilateral foot remains adequately perfused. After that,
the groin sheaths are removed with Perclose (Redwood
City, Calif) closure device deployment to achieve groin
hemostasis.
RESULTS
The clinical summary of the four patients with IABP-
induced limb ischemia who were treated with the percuta-
neous femorofemoral bypass graft is listed in the Table. The
limb ischemia was diagnosed clinically in all four patients by
means of the loss of either Doppler pedal signal or palpable
pedal pulses after the IABP insertion. There was no peripro-
cedural morbidity or mortality. The percutaneous tempo-
rary femorofemoral bypass graft was a successful means of
resolving IABP-induced limb ischemia in all patients. In a
mean follow-up period of 7.0 ± 4.8 months, there was no
recurrent ischemia, limb loss, or groin-related infection.
DISCUSSION
Since the introduction of percutaneous insertion in
1979, the use of the IABP as a temporary circulatory assist
device in patients with failing myocardium has been preva-
lent. Numerous studies that examined IABP-related prob-
lems have found that limb ischemia was by far the most
common complication, with an incidence as high as
17.4%.3,5 Ischemia caused by IABP insertion may be the
result of a combination of factors, which include luminal
obstruction of the IABP catheter, vessel spasm, throm-
boembolism, and dissection of the ileofemoral arterial seg-
ment.6 Regardless of the mechanism of the limb ischemia,
the therapeutic objective is to restore the limb perfusion
by either weaning the IABP as soon as clinically possible
or performing an operative extra-anatomic bypass grafting
procedure in IABP-dependent patients. The operative
treatment of choice for IABP-related limb ischemia is an
extra-anatomic femorofemoral bypass grafting procedure,
in which a prosthetic graft is placed in a subpubic tunnel
between the groins. A disadvantage of this bypass graft is
the relatively high incidence of groin-related wound com-
plications, which can occur in as many as 23% of patients
with type 1 diabetes mellitus.7
Fig 2. The dilators of both introducer sheaths were trimmed to
a 2-cm segment. An 8-mm PTFE graft was connected to the end
of each dilator and secured with 2-0 silk ligatures. The dilators
were inserted to their respective introducer sheaths.
Fig 3. The insertion of the dilator into the introducer sheath
kept the one-way valve open, which established a femorofemoral
bypass graft from the contralateral common femoral artery to the
ipsilateral ischemic SFA. A heparinized saline solution was infused
via the side port of the contralateral introducer sheath to maintain
a prothrombin time 1.5 times the baseline level.
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In this report, we describe an endovascular technique
for establishing a percutaneous temporary femorofemoral
bypass graft at bedside in patients in whom limb ischemia
developed after IABP insertion. All four patients in our
series who underwent this temporary bypass graft place-
ment had a good clinical outcome in a mean follow-up
period of 7.0 ± 4.8 months. No recurrent ischemia or limb
loss occurred after the removal of the temporary bypass
grafts in our patients. With certain considerations, we
believe this percutaneous temporary femorofemoral
bypass graft is applicable in selected patients. First, the
contralateral femoral pulse must be palpable so that it can
be used as a donor artery. It is not uncommon for IABP-
dependent cardiac patients to have co-existent atheroscle-
rotic occlusive disease, particularly in the aortoiliac
segment. The lack of palpable pulse in the contralateral
femoral artery is suggestive of aortoiliac occlusive disease,
and the placement of an introducer sheath in the con-
tralateral diseased femoral artery may render the donor
limb ischemic. Another important consideration in per-
forming this percutaneous bypass grafting procedure is the
use of ultrasound scanning as a means of identifying the
ischemic SFA below the IABP site. In addition, we’ve
found that the Micropuncture set is particularly useful in
accessing the SFA with direct ultrasound scanning guid-
ance. The Micropuncture set uses a 21-gauge puncture
needle with a 0.018-in guidewire, which permits cannu-
lating small-size vessels with relative ease. We prefer to
cannulate the SFA with an Arrow Super Flex introducer
sheath, which has a flexible metal-reinforced shaft. This
allows the sheath to be positioned away from the IABP
catheter without causing a kink in the introducer sheath.
Once the IABP is weaned and removed from the
patient, the femorofemoral PTFE graft should be test-
clamped before being disconnected from the groins.
While the femorofemoral graft is test-occluded, the pres-
ence of either a Doppler scanning pedal signal or palpable
pedal pulses in the ipsilateral foot implies an adequate
antegrade flow in the previously IABP-inserted ile-
ofemoral artery. The femorofemoral graft can then be dis-
connected from the groin sheaths, which can be removed
safely. If the test-occlusion of the PTFE graft leads to the
disappearance of the distal Doppler scanning signal, it
implies that the ipsilateral ileofemoral artery remains
occluded despite the removal of the IABP catheter. In
such a situation, the patient should undergo operative
repair with either an ileofemoral thrombectomy or a for-
mal femorofemoral bypass grafting procedure. Although
no patient in our series required such a procedure, we
believe this precaution should be followed as a means of
ensuring that the removal of the temporary femoro-
femoral graft does not lead to recurrent limb ischemia.
In conclusion, we describe a percutaneous technique for
establishing a temporary femorofemoral bypass graft in
IABP-dependent patients with limb ischemia. This approach
was successful in maintaining adequate limb perfusion in all
patients treated in our series, and no procedural-related
morbidity, including ischemic or infection complications,
occurred in the follow-up period. We believe that the tran-
sient nature of the percutaneous femorofemoral bypass graft
obviates the potential graft infection or wound complica-
tions associated with the formal extra-anatomic bypass graft.
This percutaneous temporary femorofemoral bypass grafting
procedure should be considered as a treatment option in
patients with IABP-related limb ischemia.
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Clinical summary of four patients with intra-aortic balloon pump-associated limb ischemia who were treated with a per-
cutaneous temporary femorofemoral bypass graft
Indication Onset of Duration of
Patient for IABP ischemia* PTFFBG Result at discharge Follow-up period Result in follow-up
1 Post-CABG LV support Immediate 3 days Palpable pedal pulses 4 months Palpable pedal pulses
2 Unstable angina 4 hours 5 days Doppler scanning pedal signal 12 months Doppler scanning pedal signal
3 Cardiogenic shock 30 minutes 3 days Palpable pedal pulses 10 months Palpable pedal pulses
4 Left ventricular failure 5 hours 4 days Doppler scanning pedal signal 2 months Doppler scanning pedal signal
*Onset of ischemia after IABP insertion.
IABP, Intra-aortic balloon pump; CABG, coronary artery bypass graft; LV, left ventricle; PTFFBG, percutaneous temporary femorofemoral bypass graft.
